Skip to main content
Top
Published in: Supportive Care in Cancer 5/2005

01-05-2005 | Editorial

Bad news in oncology: which are the right words?

Authors: Roland A. Ammann, Leila Baumgartner

Published in: Supportive Care in Cancer | Issue 5/2005

Login to get access

Excerpt

Communicating good news is usually easy. Communicating bad news is difficult. And communicating very bad news—is part of the “daily routine” work of every oncologist. But it is not routine work at all, and it definitely is difficult, and more than that. The ancient custom to kill the person who communicates the bad news has subsided, admittedly. But it is still a part of our work which we sometimes fear, and which can leave us frustrated and feeling quite helpless. On the one hand it is known that the information we give is an important part of the treatment itself, with effects at least on quality of life [5], while on the other hand evidence suggests that we do not do a particularly good job in giving it [8]. If only we knew which are the right words for these situations, e.g., the disclosure of diagnosis of malignancy, of metastatic disease [2], of relapse, or of life-threatening complications, be it to the patient himself, or to the parents in the case of children with cancer. …
Literature
1.
go back to reference Argyle M (1975) Bodily communication. Methuen, London Argyle M (1975) Bodily communication. Methuen, London
2.
go back to reference Butow PN, Dowsett S, Hagerty R, Tattersall MH (2002) Communicating prognosis to patients with metastatic disease: what do they really want to know? Support Care Cancer 10:161–168CrossRefPubMed Butow PN, Dowsett S, Hagerty R, Tattersall MH (2002) Communicating prognosis to patients with metastatic disease: what do they really want to know? Support Care Cancer 10:161–168CrossRefPubMed
3.
go back to reference Flammer A (1997) Einführung in die Gesprächspsychologie [Introduction to the psychology of conversation]. Huber, Bern Flammer A (1997) Einführung in die Gesprächspsychologie [Introduction to the psychology of conversation]. Huber, Bern
4.
go back to reference Frick RW (1985) Communicating emotion. The role of prosodic features. Psychol Bull 97:412–429CrossRef Frick RW (1985) Communicating emotion. The role of prosodic features. Psychol Bull 97:412–429CrossRef
5.
go back to reference Kim Y, Roscoe JA, Morrow GR (2002) The effects of information and negative affect on severity of side effects from radiation therapy for prostate cancer. Support Care Cancer 10:416–421CrossRefPubMed Kim Y, Roscoe JA, Morrow GR (2002) The effects of information and negative affect on severity of side effects from radiation therapy for prostate cancer. Support Care Cancer 10:416–421CrossRefPubMed
6.
go back to reference Scherer KR (1979) Nonlinguistic vocal indicators of emotion and psychopathology. In: Izard CE (eds) Emotions in personality and psychopathology. Plenum, New York Scherer KR (1979) Nonlinguistic vocal indicators of emotion and psychopathology. In: Izard CE (eds) Emotions in personality and psychopathology. Plenum, New York
7.
go back to reference Scrimin S, Axia G, Tremolada M, Pillon M, Capello F, Zanesco L (2005) Conversational strategies with parents of newly diagnosed leukemic children. An analysis of 4880 conversational turns. Support Care Cancer (this issue) Scrimin S, Axia G, Tremolada M, Pillon M, Capello F, Zanesco L (2005) Conversational strategies with parents of newly diagnosed leukemic children. An analysis of 4880 conversational turns. Support Care Cancer (this issue)
8.
9.
go back to reference Watzlavick P, Beavin JH, Jackson DD (1967) Pragmatics of human communication. Norton, New York Watzlavick P, Beavin JH, Jackson DD (1967) Pragmatics of human communication. Norton, New York
Metadata
Title
Bad news in oncology: which are the right words?
Authors
Roland A. Ammann
Leila Baumgartner
Publication date
01-05-2005
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 5/2005
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-004-0712-4

Other articles of this Issue 5/2005

Supportive Care in Cancer 5/2005 Go to the issue

Forthcoming Meetings

Forthcoming Meetings 13/5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine